Ischaemia or reperfusion: Which is a main trigger for changes in nitric oxide mRNA synthases expression?

European Journal of Clinical Investigation

Volumn 35, Issue 9, 2005, Pages 546-550

  Pevni, D ^a   Frolkis, Inna ^a,b   Shapira, I ^a   Schwartz, D ^a   Schwartz, I F ^a   Chernichovski, T ^a   Lev Ran, O ^a   Sharony, R ^a   Uretzky, G ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Ischaemia; mRNA; Nitric oxide synthases; Reperfusion

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; MESSENGER RNA;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DOWN REGULATION; HEART HEMODYNAMICS; ISCHEMIA; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION; STATISTICAL ANALYSIS;

ANIMALS; ENDOTHELIUM, VASCULAR; HEART ARREST, INDUCED; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIUM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, WISTAR; RNA, MESSENGER; VENTRICULAR DYSFUNCTION, LEFT;

EID: 24144467794     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2005.01553.x     Document Type: Article

References (34)

1. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effect of cytokines on the heart mediated by nitric oxide. Science 1992;257:387-9.
2. Chung MK, Gulik TS, Rotondo RE, Schreiner GF, Lange LG. Mechanism of cytokine inhibition of β-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes. Impairment of signal transduction. Circ Res 1990;67:753-63.
3. Wang P, Zweier JL. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart: evidence of peroxynitrite-mediated reperfusion injury. J Biol Chem 1996;271:29223-30.
4. 2+ dependent nitric oxide synthase in bovine aortic endothelial cells. Am J Physiol 1995;269:C757-65.
5. Oral H, Kapadia S, Nakano M, Torre-Amione G, Lee J, Lee-Jackson D et al. Tumor necrosis factor-alpha and the failing human heart. Clin Cardiol 1995;18 (Suppl. IV):20-2.
6. Avontuur JAM, Bruining HA, Ince S. Inhibition of nitric oxide synthesis causes myocardial ischemia in endotoxemic rats. Circ Res 1995;76:418-25.
7. Heger J, Godecke A, Fdlogel U, Merx MW, Molojavyi A, Kühn-Veiten WN et al. Cardiac-specific overexpression of inducible nitric oxide synthase does not result in severe cardiac dysfunction. Circ Res 2002;90:93-5A.
8. Gurevitch J, Frolkis I, Yuhas Y, Paz Y, Matsa M, Mohr R et al. Tumor necrosis factor-alpha released from the isolated heart undergoing ischemia and reperfusion. J Am Coll Cardiol 1996;28:247-52.
9. Frolkis I, Gurevich J, Yuhas Y, Iaina A, Wollman Y, Chernichovski T et al. Interaction between paracrine tumor necrosis factor-alpha and paracrine angiotensin II during myocardial ischemia. J Am Coll Cardiol 2001;37:316-22.
10. Pevni D, Frolkis I, Iaina A, Wollman T, Chernichovski T, Shapira I et al. Protamine cardiotoxicity and nitric oxide. Eur J Cardiothorac Surg 2001;20:147-52.
11. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: extraction of RNA with guanidium thiocyanate followed by centrifugation in serum chloride solution. In: Nolan SH, ed. Laboratory Manual. Book 1. Cold Spring Harbor Laboratory Series. New York, NY: Cold Spring Harbor; 1989.pp. 719-32.
12. Ikeda U, Shimada K. Nitric oxide and cardiac failure. Clin Cardiol 1997;20:837-41.
13. Vergely C, Tabard A, Maupoil V, Rochette L. Isolated perfused rat hearts release secondary free radicals during ischemia reperfusion injury: cardiovascular effects on the spin trap alpha-phenyl N-tert-butylnitrone. Free Radic Res 2001;35 (5):475-89.
14. Chandrasekar B, Smith JB, Freeman GL. Ischemia-reperfusion of rat myocardium activates nuclear factor-Kappa B and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine. Circulation 2001;103:2296-302.
15. Nossuli TO, Frangogiannis NG, Knuefermann P, Lakshminarayanan V, Dewald O, Evans AJ et al. Brief murine myocardial I/R induces chemokines in a TNF-alpha-independent manner: role of oxygen radicals. Am J Physiol Heart Circ Physiol 2001;281:H2549-58.
16. Nossuli TO, Lakshminarayanan V, Baumgarten G, Taffet GE, Ballantyne CM, Michael LH et al. A chronic mouse model of myocardial ischemia-reperfusion: essential in cytokine studies. Am J Physiol Heart Circ Physiol 2000;278:H1049-55.
17. Fan H, Sun B, Gu Q, Lafond-Walker A, Cao S, Becker LC. Oxygen radicals trigger activation of NF-kappa B and AP-1 and up-regulation of ICAM-1 in reperfused canine heart. Am J Physiol Heart Circ Physiol 2002;282:H1778-86.
18. Igarashi J, Nishida M, Hoshida S, Yamashita N, Kosaka H, Hori M et al. Inducible nitric oxide synthase augments injury elicited by oxidative stress in rat cardiac myocytes. Am J Physiol 1998;274:C245-52.
19. Parrino PE, Laubach VE, Gaughen JR Jr, Shockey KS, Wattsman TA, King RC et al. Inhibition of inducible nitric oxide synthase after myocardial ischemia increases coronary flow. Ann Thorac Surg 1998;66:733-9.
20. Kanno S, Lee PC, Zhang Y, Ho C, Griffits HP, Shears LL II et al. Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase. Circulation 2000;101:2742-8.
21. Sharp BR, Jones SP, Rimmer DM, Leffer DJ. Differential response to myocardial reperfusion injury in eNOS-deficient mice. Am J Physiol Heart Circ Physiol 2002;282:H2422-6.
22. Brunner F, Maier R, Andrew P, Wolkart G, Zechner R, Mayer B. Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Cardiovasc Res 2003;57:55-62.
23. 2+ dependent nitric oxide synthase in bovine aortic endothelial cells. Am J Physiol 1995;269:C757-65.
24. Smith TW, Balligand JL, Kaye DM, Wiviott SD, Simmons WW, Han X et al. The role of NO pathway in the control of cardiac function. J Card Fail 1996;2 (4 Suppl.):S141-7.
25. Tatsumi T, Keira N, Akashi K, Kobara M, Matoba S, Shiraishi J et al. Nitric oxide-cGMP pathway is involved in endotoxin-induced contractile dysfunction in rat hearts. J Appl Physiol 2004;96:853-60.
26. Karim SM, Rhee AY, Given AM, Faulx MD, Hoit BD, Brozovich FV. Vascular reactivity in heart failure. Role of myosin light chain phosphatase. Circ Res 2004;95 (6):612-8.
27. Laude K, Richard V, Thuillez C. Coronary endothelial cells: a target of ischemia reperfusion and its treatment? Arch Mal Coeur Vaiss 2004;97:250-4.
28. Paz Y, Frolkis I, Pevni D, Shapira I, Yuhas Y, Iaina A et al Effect of tumor necrosis factor-alpha on endothelial and inducible nitric oxide synthase messenger ribonucleic acid expression and nitric oxide synthesis in ischemic and nonischemic isolated rat heart. J Am Coll Cardiol 2003;42:1299-305.
29. Lincoln TM. Cyclic GMP and mechanisms of vasodilation. Pharmacol Ther 1989;41:479-502.
30. Shiode N, Morishima N, Nakayama K, Yamagata T, Matsuura H, Kajiyama G. Flow-mediated vasodilation of human epicardial coronary arteries: effect of inhibition of nitric oxide synthesis. J Am Coll Cardiol 1996;27:304-10.
31. Balligand JL, Kobzik L, Han X, Kaye DM, Belhassen L, O'Hara DS et al. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem 1995;270 (24): 14582-6.
32. Reithmann S, Werdan K. TNF-α decreases inositol phosphate formation and phosphatidylinositol-biphosphate synthesis in rat cardiomyocytes. Naunyn Schmiedbergs Arch Pharmacol 1994;349:175-82.
33. 2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J Biol Chem 1993;268:26286-95.
34. Balligand JL, Ungureanu D, Kelly RA, Kobzik L, Pimental D, Michel T et al. Abnormal contractile function due to induction of nitric oxide synthesis in the rat myocytes follows exposure to activated macrophage-medium. J Clin Invest 1993;91:2314-9.